Zjpharma

What Zjpharma does

Zjpharma (ZJPHARMA INC.) is a privately held B2B pharmaceutical and nutritional products distributor and regulatory intermediary founded around 2000, headquartered in Zhuhai, China with additional offices in Shijiazhuang (North China, co-located with the contracted Rainbowlabs laboratory) and Pomona, California. The company serves as the exclusive sales and regulatory agent in North America and Europe for a portfolio of major Chinese API manufacturers including Hebei Jianmin, Ningxia Tairui, CSPC, NCPC, and Jinhua Mingzhu, distributing antibiotics, anti-parasitics, vitamins, nutritional supplements, plant extracts, finished human and veterinary drugs, excipients, feed additives, food ingredients, and probiotics/enzymes to global pharmaceutical and nutritional customers including Pfizer and Novartis.

The company monetizes through two principal streams: distribution transaction revenue on API and finished-product sales, and professional services revenue from regulatory support packages that include DMF/VMF/EDMF filing, source qualification, cGMP auditing, CAPA, and quality engineering management. Its underlying technology is the contracted Rainbowlabs testing facility, certified by US FDA (July 2013, re-confirmed 2016), Health Canada (2014), and CNAS, enabling cGMP-grade QC release testing whose Certificates of Analysis are accepted by top US, EU, and Canadian pharmaceutical companies. The firm goes to market through enterprise field sales and channel-partner relationships, anchored by an annual calendar of 12 major global pharmaceutical industry trade shows including CPHI, IPPE, SupplySide, DCAT, and VIV ASIA. Headcount is reported in the 1,001–5,000 range; the company has remained privately held with no disclosed external funding or M&A activity.

Name

Zjpharma

Legal name

ZJPHARMA INC.

Website

https://zjpharma.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Zjpharma is a China-based B2B pharmaceutical distributor and FDA regulatory intermediary serving global pharma companies by sourcing APIs and nutritional products from Chinese manufacturers and providing cGMP quality assurance through its contracted Rainbowlabs laboratory certified by US FDA, Health Canada, and CNAS.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution and Regulatory Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medicinal and Botanical Manufacturing (325411)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833), Services-Medical Laboratories (8071)

akta.pro primary industry

Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)

akta.pro secondary industries

Analytical Development & QC Testing (Release/Stability/Potency) (HLAGAGAF), Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)

Keywords

• Pharmaceutical ingredient distribution
• FDA regulatory support services
• Active pharmaceutical ingredients
• CGMP quality assurance
• Finished dosage forms

Headquarters

HQ city

Zhuhai

HQ country

China

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Products Distribution: Distribution of pharmaceutical and nutritional products including antibiotics, anti-parasites, and vitamins to strategic partners globally. Acting as exclusive sales agent for major Chinese API manufacturers in North America and Europe.
2. Regulatory Support Services: QA and regulatory package including DMF/VMF/EDMF filing, source qualification, cGMP auditing, CAPA, and quality engineering management to help contract API manufacturers achieve FDA/COS approval.
3. Product Sales (NMP and Specialty Chemicals): Sale of specialty pharmaceutical chemicals like NMP (N-Methyl-2-pyrrolidone) and pectin products to pharmaceutical and nutritional industry customers.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Zjpharma distributes active pharmaceutical ingredients, finished dosage forms, veterinary drugs, nutritionals, plant extracts, and specialty chemicals manufactured by Chinese producers through sole-agency agreements covering North America and Europe. The company pairs product distribution with FDA regulatory support services—including DMF/VMF/EDMF filing, source qualification, cGMP auditing, CAPA, and quality engineering—delivered through its contracted FDA-certified Rainbowlabs testing laboratories. Strategic customers include Pfizer and Novartis for antibiotics, anti-parasites, and vitamins.

Product overview

Zjpharma is a leading global distributor of pharmaceutical and nutritional products operating through a network of FDA-certified testing laboratories (Rainbowlabs) and Chinese manufacturing partners. The company offers a comprehensive portfolio organized across multiple product categories: API-1 (antibiotics and pharmaceutical ingredients), API-2 (veterinary APIs), API-3 (human health APIs), Nutritionals, Plant Extracts, Human Drugs (finished dosage forms), Vet Drugs, Cosmetic/Excipients, Feeds/Trace Minerals, Food Ingredients, and Probiotics/Enzymes. Supporting the product distribution business, Zjpharma provides regulatory services including FDA audit guidance, DMF filing, cGMP auditing, and quality assurance support. The company serves as sole agent in North America and Europe for products from major Chinese manufacturers including Jianmin, Ningxia Tairui, CSPC, NCPC, and Jinhua Mingzhu. Rainbowlabs operates as the company's contracted FDA-approved testing facility, providing QC testing, R&D services, and regulatory compliance support.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical APIs (Antibiotics and Specialty APIs) First-category pharmaceutical active ingredients covering antibiotics, veterinary APIs (Lincomycin, Tylosin, Oxytetracycline), and human health APIs (Penicillin G, Gentamycin, Fluoroquinolones); many items hold FDA, CEP, or DMF certifications. Sold to global pharmaceutical manufacturers.
• Veterinary APIs (Antiparasitics and Ectoparasiticides) Second-category veterinary pharmaceutical ingredients including antiparasitics (Ivermectin, Moxidectin, Doramectin, Avermectin), ectoparasiticides (Fipronil, Flumethrin), and other veterinary drugs (Toltrazuril, Praziquantel, Fenbendazole) for animal health manufacturers.
• Human Health APIs Third-category human pharmaceutical ingredients including cardiovascular drugs (Atorvastatin, Clopidogrel, Telmisartan), anti-inflammatory drugs (Dexamethasone, Ibuprofen), and specialty APIs (Vancomycin, Heparin Sodium, Mitomycin) for finished drug manufacturers.
• Nutritionals and Vitamins Nutritional supplements including vitamins (A, B-complex, C, D3, E, K), amino acids (L-Carnitine, L-Arginine, L-Lysine), minerals, and specialty nutrients (Coenzyme Q10, Astaxanthin, Collagen, Hyaluronic Sodium, Omega fatty acids) for nutritional product manufacturers.
• Plant Extracts Natural plant-based extracts including botanical ingredients (Astragalus Extract, Ginkgo Biloba, Ginseng, Green Tea Extract), specialty compounds (Resveratrol, Silymarin, Stevia, Lutein), and carotenoids (Beta-Carotene, Zeaxanthin) for nutraceutical and food manufacturers.
• Human Drugs (Finished Dosage Forms) Finished pharmaceutical products in multiple dosage forms including capsules (Amoxyle, Ampicillin, Cefatoxim), tablets (Aspirin, Azithromycin, Captopril), powder for injection (Amoxycillin Sodium, Ceftriaxone), and injectable solutions (Gentamycin, Lincomycin, Vitamins B1/B6/B12) for human health distributors and hospitals.
• Veterinary Finished Products Veterinary pharmaceutical finished products including injectables (Amoxicillin, Ceftiofur, Ivermectin, Oxytetracycline), oral solutions (Albendazole, Enrofloxacin), and feed premix formulations (Azamethiphos, Diclazuril, Tylosin) for animal health distributors.
• Cosmetic and Pharmaceutical Excipients Cosmetic ingredients and pharmaceutical excipients including sweeteners (Acesulfame-K, Xylitol), preservatives (Methylparaben, Propylene Glycol), functional ingredients (Allantoin, Kojic Acid, Idebenone), and processing aids (Lactose, Gelatine, Magnesium Stearate) for cosmetic and pharmaceutical formulators.
• Animal Feed Additives and Trace Minerals Animal feed additives and trace minerals including amino acids (DL-Methionine, Valine), vitamins (B12), trace minerals (Copper, Zinc, Manganese, Iron chelates), and feed antibiotics (Enramycin, Maduramycin, Zinc Bacitracin) for animal feed manufacturers.
• Food Ingredients Food industry ingredients including sweeteners (Acesulfame K, Aspartame, Sucralose), acids (Citric Acid), preservatives (Sodium Benzoate, Nisin), and functional ingredients (Xanthan Gum, Vanillin, Pectin, Phycocyanin) for food manufacturers.
• Probiotics and Enzymes Probiotic strains and enzyme products including Bacillus species (B. Licheniformis, B. Subtilis), digestive enzymes (Amylase, Protease, Lipase, Cellulase), and specialty enzymes (Phytase, Beta-Glucanase, Xylanase, Sodium Butyrate) for nutritional and animal feed producers.
• FDA-Approved Testing Laboratory Services (Rainbowlabs) Contracted FDA-approved testing laboratory providing QC testing, on-site QA support, API and formulation R&D, and regulatory compliance services. The first Chinese third-party testing laboratory to pass FDA inspection with Zero 483, holding simultaneous US FDA, Health Canada, and CNAS approval. Services are sold to pharmaceutical manufacturers requiring audited release testing.
• FDA Regulatory Support Services Regulatory consulting service package including DMF/VMF/EDMF filing, source qualification, cGMP auditing, CAPA implementation, quality engineering management, and FDA inspection guidance. Sold to Chinese API manufacturers seeking FDA/COS approval for their manufacturing sites and products.
• QC Testing Services Quality control testing services with dedicated QC professionals issuing Certificates of Analysis accepted by top US, EU, and Canadian pharmaceutical companies. Sold to API and nutraceutical manufacturers as part of release testing programs.
• QA (Quality Assurance) Services On-site quality assurance and quality commonwealth services established between Rainbowlabs and contract manufacturers, ensuring integrity and consistency of quality systems per international cGMP standards. Sold to API manufacturers as audit support.
• Pharmaceutical R&D Services (CRO) Contract research organization offering new pharmaceutical formulation development, API discovery, and industrialization services to the global pharmaceutical and nutritional industry through ZJPHARMA's R&D team.
• Strategic Sourcing Services Strategic sourcing solutions bundling on-site QA audit, cGMP compliance, quality control, and logistics services for API and nutraceutical procurement. Sold to global pharmaceutical and nutritional product buyers.
• NMP (N-Methyl-2-pyrrolidone) Pharmaceutical-Grade Solvent Pharmaceutical-grade NMP (N-Methyl-2-pyrrolidone) solvent from US FDA-approved labs, used as a solvent, reaction medium, and cleaning agent in pharmaceutical and chemical industry applications; approximately 70 million kg per year capacity.

Quantifiable outcome

• Multiple FDA approvals with Zero 483 observations achieved for contract manufacturers
• +2 more outcomes

Named customers12 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Ten partnerships are on record, tiered core.

• PfizercoreStrategic or Co-development PartnerStrategic partner receiving antibiotics, anti-parasites, and vitamins from Zjpharma's product portfolio
• NovartiscoreStrategic or Co-development PartnerStrategic partner receiving antibiotics, anti-parasites, and vitamins from Zjpharma's product portfolio
• Rainbow Labs (Shijiazhuang Rainbowlabs Pharmaceutical Technology Co., Ltd)coreStrategic or Co-development PartnerContracted third-party FDA-certified testing laboratory providing QC testing, on-site QA backup, API & formulation R&D, and regulatory support. The only lab approved by US FDA, Health Canada, and CNAS simultaneously.
• Hebei Jianmin (Jianmin)coreChannel Partner/ Reseller/ DistributorMajor Chinese API manufacturer; Zjpharma is sole agent in North America and Europe
• Ningxia TairuicoreChannel Partner/ Reseller/ DistributorMajor Chinese API manufacturer; Zjpharma is sole agent in North America and Europe
• CSPC (China Science Publishing)coreChannel Partner/ Reseller/ DistributorMajor Chinese API manufacturer; Zjpharma is sole agent in North America and Europe
• NCPC (North China Pharmaceutical Corporation)coreChannel Partner/ Reseller/ DistributorMajor Chinese pharmaceutical manufacturer; Zjpharma is sole agent in North America and Europe
• Zhuhai Jida (Jinhua Mingzhu)coreChannel Partner/ Reseller/ DistributorMajor Chinese manufacturer; Zjpharma is sole agent in North America and Europe
• Livzon GroupcoreStrategic or Co-development PartnerManufacturing partner for Moxidectin API; collaborated on successful FDA NDA approval for river blindness treatment
• Medicines Development for Global Health (MDGH)coreStrategic or Co-development PartnerAustralian not-for-profit biopharmaceutical company; Zjpharma supplied Moxidectin API, filed DMF, and provided FDA audit support leading to FDA approval of first human moxidectin treatment

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Lupin Limited: Lupin is a major Indian pharmaceutical manufacturer and global distributor of APIs and finished dosage forms, with strong US generic presence. Comparable to Zjpharma as a non-Western API/distribution operator serving Western pharma and generics markets.
• Aurobindo Pharma: Aurobindo is one of the largest Indian API and finished-formulation manufacturers, with extensive US/EU distribution of antibiotics and other generics. Directly comparable as a non-Western API/distribution competitor with FDA compliance capability serving the same global pharma buyers.
• Zhejiang Huahai Pharmaceutical: Zhejiang Huahai is a leading Chinese manufacturer of APIs (notably cardiovascular and antiretrovirals) with significant FDA-approved supply and global distribution. Comparable to Zjpharma in targeting Western pharma customers with FDA-compliant Chinese API supply, though it operates more as a manufacturer than an agent/distributor.
• Apeloa Pharmaceutical: Apeloa is a major Chinese API manufacturer and distributor with global reach, particularly in antibiotics and intermediates. Directly comparable to Zjpharma as both serve as Chinese API exporters targeting Western pharmaceutical markets, though Apeloa is more manufacturer-led than distribution-led.
• Dr. Reddy's Laboratories: Dr. Reddy's is an Indian integrated pharmaceutical company with significant API manufacturing and global distribution of generics including antibiotics. Directly comparable as an API-to-distribution operator serving regulated markets from a non-Western manufacturing base.

Broad incumbents

• WuXi AppTec: WuXi AppTec is the leading Chinese CRO/CDMO with extensive global pharma services including API development and manufacturing. Adjacent peer to Zjpharma via shared Chinese API/global-pharma linkage, though WuXi's business is services-led (CRO/CDMO) rather than distribution-led.
• Shanghai Pharmaceuticals Holding: Shanghai Pharmaceuticals is a large state-backed Chinese pharmaceutical manufacturer and distributor with broad API, formulation, and distribution operations. Comparable to Zjpharma as a Chinese pharma exporter to global markets, though much larger and more vertically integrated rather than distribution-led.
• Teva Pharmaceutical Industries: Teva is the world's largest generic pharmaceutical manufacturer with global API and finished-formulation distribution. Comparable to Zjpharma as a global generic API/distribution platform serving Western markets, though at vastly greater scale and with proprietary manufacturing rather than agency model.
• China Resources Pharmaceutical Group: China Resources Pharmaceutical is one of China's largest state-owned pharmaceutical conglomerates covering manufacturing, distribution, and retail. Comparable as a Chinese pharmaceutical distribution platform with global ambitions, though operates at much greater scale and breadth than Zjpharma.

Emerging players

• Asymchem Laboratories: Asymchem is a Chinese CDMO with growing API manufacturing and global pharma services. Comparable emerging Chinese API/services player targeting Western pharma customers, though more services/contract-manufacturing oriented than Zjpharma's agency-distribution model.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/zjpharma-inc.

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zjpharma